Method: IHC
Detects glypican-3 protein, highly expressed in hepatocellular carcinoma (HCC) and some germ cell tumours (yolk sac tumours). Used to confirm HCC diagnosis and differentiate it from benign liver lesions.
Glypican-3 is a sensitive marker for HCC and helps distinguish liver cancer from benign tumours. In combination with HepPar-1 and arginase-1, it provides reliable HCC confirmation — critical before liver-specific treatments.
No preparation needed — performed on biopsy or surgical tissue.
Price (MRP)
NPR 3,800
Order as a gift© 2026 Aashirbad Care. All rights reserved.